Semaglutide: A Promising Ally Against Alzheimer’s?

In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.

Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.

Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.

Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.

Rong xu

Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.

According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.

“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”

Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.

For more information, please contact Patty Zamora at [email protected].

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Florida Homeowners See Major Spring Insurance Savings as Market Finally Stabilizes

Florida homeowners are getting long‑awaited relief this spring as insurance premiums drop across the state, with some counties seeing reductions of up to 14 percent. After years of skyrocketing rates and insurer withdrawals, a series of legislative reforms has attracted new companies, reduced lawsuits, and restored competition—leading to lower costs for more than 330,000 Citizens policyholders and multiple private‑market rate cuts. This shift is boosting not only homeowners, but also Florida’s broader economy and real estate market, offering valuable insights for professionals in real estate, insurance, mortgage, and finance.

AI Listing Images Are Creating a New Trust Problem in Real Estate

Artificial intelligence has transformed real estate marketing by making it easy to generate polished, digitally enhanced listing photos. But as AI tools increasingly replace reality with idealized versions of homes, a new issue has emerged: housefishing. Buyers and renters are showing up to properties that look nothing like the online images, leading regulators to step in and require transparency. With laws like California’s newly enacted Assembly Bill 723, the industry is being pushed toward clearer labeling and ethical use of AI. As trust becomes a growing concern, real estate professionals must balance innovation with accuracy to stay compliant and credible.

Massachusetts Moves to Strengthen Fair Housing Training for Real Estate Agents

Massachusetts has unanimously advanced bill S.2947, a major push to curb housing discrimination by expanding fair housing education requirements for real estate agents. The proposal increases training hours for both current and future licensees and doubles penalties for violations, marking a significant shift toward stronger consumer protections and higher professional standards across the state’s housing market.

How Rising Energy Costs Are Quietly Reshaping the Hudson Valley Real Estate Market

Energy costs have moved from a background expense to a major force influencing affordability, property values, and development across the Hudson Valley. Aging housing stock, grid constraints, and rising utility bills are reshaping both residential and commercial real estate decisions—rewarding energy‑efficient properties and pressuring households already struggling to balance essential expenses.

How AI Is Becoming the New Power Tool for Real Estate Professionals

AI is transforming the daily workflow of real estate pros by speeding up marketing, simplifying client communication, and sharpening pricing strategies. As highlighted in an NBC 6 feature, agents are using AI to draft listing descriptions, generate social media content, organize inquiries, and analyze market data in minutes. Whether you're new to the industry or an experienced agent, AI is quickly becoming an essential tool for working smarter and staying competitive.

14-Hour CE Renewal for Florida Real Estate: Choose Your Learning Style